Welcome to our dedicated page for JRSIS HEALTH CARE news (Ticker: JRSS), a resource for investors and traders seeking the latest updates and insights on JRSIS HEALTH CARE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JRSIS HEALTH CARE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JRSIS HEALTH CARE's position in the market.
JRSIS Health Care Corporation (OTCQX: JRSS) reported a 13% increase in revenues for the fiscal year ending December 31, 2020, totaling $35.71 million, up from $31.46 million in 2019. EBITDA rose to $9.03 million, a significant increase from $5.25 million year-over-year. Operating expenses also increased by 12%, primarily due to higher medical consumables costs and increased staffing. Despite a 51% rise in per capita medical expenses amid the COVID-19 pandemic, patient service revenues increased by 27%.
FAQ
What is the market cap of JRSIS HEALTH CARE (JRSS)?
